BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4951058)

  • 1. A comparative study of spironolactone and hydroflumethiazide alone and together in the treatment of hypertension.
    Jamil MA
    Guys Hosp Rep; 1971; 120(3):207-19. PubMed ID: 4951058
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone and hydroflumethiazide in the treatment of hypertension.
    Akbar FA; Boston PF; Chapman J; Pearce MY
    Br J Clin Pract; 1981 Sep; 35(9):317-21. PubMed ID: 7034762
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 4. A spironolactone-hydroflumethiazide combination in hypertension.
    Practitioner; 1971 Mar; 206(233):412-5. PubMed ID: 4929196
    [No Abstract]   [Full Text] [Related]  

  • 5. Duration of effect of single daily doses of reserpine and hydroflumethiazide evaluated by noninvasive technology in hypertensive patients.
    Gifford RW; Williams GW; Vidt DG; Bolen K; Acker C
    Cleve Clin Q; 1982; 49(4):209-18. PubMed ID: 7168911
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldactide and dytide.
    Drug Ther Bull; 1967 Oct; 5(21):82-3. PubMed ID: 6077512
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral thiazide diuretics in the treatment of hypertension in Nigeria.
    Salako LA
    West Afr Med J Niger Pract; 1971 Oct; 20(5):320-3. PubMed ID: 5136799
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antihypertensive effects of hydroflumethiazide and prazosin].
    Andersen GS
    Ugeskr Laeger; 1980 Jun; 142(24):1555-7. PubMed ID: 7414715
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F; Leya A
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria.
    Olatunde A; Akinkugbe OO; Carlisle R
    East Afr Med J; 1977 Apr; 54(4):194-201. PubMed ID: 902626
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diuretics. 5. Effects of single or combined administration of diuretics in normal or spontaneously hypertensive rats].
    Suzuki Y; Kojima K; Shinoda M; Yamagami I
    Nihon Yakurigaku Zasshi; 1972 May; 68(3):276-89. PubMed ID: 5066354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Spironolactone in essential hypertension. Controlled study on the dose-response relationship].
    Orabona ML; Maiorano G; Loiacono N
    Minerva Cardioangiol; 1975 Dec; 23(12):866-70. PubMed ID: 1232582
    [No Abstract]   [Full Text] [Related]  

  • 13. [The combination of aldosterone blockaders with thiazides in he treatment of arterial hypertension].
    Serbano PA; Stevens H; Chávez Lara B
    Arch Inst Cardiol Mex; 1970; 40(2):195-204. PubMed ID: 5489740
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind evaluation of the therapeutic efficacy of salutensin versus hydropres-50 in essential hypertension.
    Cangiano JL; Bloomfield DK
    Curr Ther Res Clin Exp; 1970 Feb; 12(2):78-83. PubMed ID: 4984323
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
    Yonga GO; Ogola EN; Orinda DA
    East Afr Med J; 1993 Nov; 70(11):696-700. PubMed ID: 8033771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
    Merkle GW; Bader PI; Creason PL; Townsend DW; Conn PS; Lakes MK; Campbell NM
    J Indiana State Med Assoc; 1981 Jul; 74(7):444-9. PubMed ID: 7024422
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension.
    Pinto JM
    East Afr Med J; 1981 Jan; 58(1):44-50. PubMed ID: 7011783
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct positive inotropic cardiac effect of aldactone (spironolactone, canrenoate-K)].
    Schröder R; Ramdohr B; Hüttemann U; Schüren KP
    Dtsch Med Wochenschr; 1972 Oct; 97(41):1535-8. PubMed ID: 4561711
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension in the elderly: review of therapy with a hydroflumethiazide-reserpine combination.
    Elkowitz EB
    J Am Geriatr Soc; 1979 Nov; 27(11):507-10. PubMed ID: 489858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.